NetScientific announces placing, wider interim loss
1st Oct 2015 10:55
(ShareCast News) - NetScientific said it will raise up to £20m through a placing and additional fundraising to accelerate the development of its two lead portfolio companies, Vortex Biosciences and Wanda, and reported a bigger first-half loss. The biomedical healthcare group said it will raise aroun
Read moreNetScientific reshuffles Frontier BioSciences ownership in portfolio review
18th Sep 2015 08:56
(ShareCast News) - NetScientific has sold its 49.9% stake in Frontier BioSciences. The biomedical and healthcare technology group is reviewing its portfolio, and has sold their stake to Zahra Holdings. Zahra is wholly-owned by the family trusts of NetScientific's former chief executive Farad Azima.
Read moreNetScientific's Vortex Biosciences secures critical US patent
15th Sep 2015 11:23
(ShareCast News) - NetScientific's portfolio company, Vortex BioSciences, has been granted a critical patent on its core technology in the US. The granted patent, licensed exclusively to Vortex from UCLA, was also recently issued in China and Australia and covers its core technology of inertial micr
Read moreNetScientific appoints Steve Curd as Wanda CEO
9th Sep 2015 13:33
(ShareCast News) - NetScientific has appointed Steve Curd as chief executive officer of its portfolio company, Wanda, and head of the group's digital health franchise, of which Wanda is the key asset. Curd will join the group on 14 September to oversee the growth and delivery of its digital health p
Read moreNetscientific surges as portfolio company launches respiratory test
4th Aug 2015 11:29
(ShareCast News) - Shares in Netscientific jumped almost 7% on Tuesday, after the group said its subsidiary ProAxsis had launched its ProteaseTag immunoassay kit to research laboratories. The biomedical and healthcare technology investor described the launch of ProteaseTags, smart molecules that tra
Read moreNetScientific granted European patent for glucose measuring technology
15th Jul 2015 12:31
(ShareCast News) - NetScientific has been granted its first European patent for non-invasive technology to measure glucose level in the blood via contact with the skin, a potentially important development for diabetes sufferers. The granting of a patent on the product, which was co-developed by its
Read moreNetScientific appoints new CEO
11th May 2015 14:41
Biomedical and healthcare group NetScientific appointed François Martelet as its new chief executive and board director. Chairman Richard Sykes, who will revert his executive chairman position to non-executive, said: "Martelet further strengthens NetScientific's management team at a time when a numb
Read moreNetScientific forms strategic alliance with start-up investor
26th Mar 2014 13:29
AIM-listed NetScientific, a biomedical and healthcare technology investment group, has formed a strategic alliance with San Francisco-based Breakout Labs, it announced Wednesday. Under the agreement NetScientific will invest up to $0.25m in Breakout Labs portfolio companies that fit its investment
Read more